Medical Condition News

RSS

Enrollment complete in BDSI's pivotal pharmacokinetic study of BNX for opioid dependence

BioDelivery Sciences International, Inc. announced that enrollment and the clinical portion of the pivotal pharmacokinetic study for BEMA Buprenorphine/Naloxone (BNX) for the treatment of opioid dependence has been completed.

20 Aug 2012

FDA approves InSightec's ExAblate Neuro system clinical trial for tremor dominant Parkinson's Disease

InSightec Ltd, the global leader in MR guided Focused Ultrasound (MRgFUS), announced that it has received approval from the US Food and Drug Administration to begin a Phase I clinical trial evaluating the use of its ExAblate Neuro system for the treatment of patients with tremor dominant Parkinson's Disease.

20 Aug 2012

Juventas commences treatment in JVS-100 Phase II STOP-HF trial for late stage heart failure

Juventas Therapeutics, a privately-held clinical-stage company developing novel regenerative therapies for treatment of cardiovascular disease, reports treating the first patient in its STOP-HF trial.

20 Aug 2012

Protein toxic to nerve cells in AD also contributes to memory loss

The underlying causes of Alzheimer's disease are not fully understood, but a good deal of evidence points to the accumulation of β-amyloid, a protein that's toxic to nerve cells. β-amyloid is formed by the activity of several enzymes, including one called BACE1. Most Alzheimer's disease patients have elevated levels of BACE1, which in turn leads to more brain-damaging β-amyloid protein.

20 Aug 2012

Abbott's XIENCE Xpedition Everolimus Eluting Coronary Stent System receives CE Mark in Europe

Abbott today announced that the XIENCE Xpedition Everolimus Eluting Coronary Stent System received CE Mark in Europe for the treatment of coronary artery disease.

20 Aug 2012

Cervical cancer screening: an interview with Alastair Atkinson, CEO of DySIS Medical Ltd

Cervical Cancer is a tragic disease. First and foremost, because it is entirely preventable if the early symptoms are detected in a timely manner

20 Aug 2012

GORE Hybrid Vascular Graft receives CE Mark approval

W. L. Gore & Associates (Gore) has received CE Mark for the GORE Hybrid Vascular Graft. The graft is designed to expand treatment options for optimal outflow by maximizing the number of access sites available.

20 Aug 2012

Binge drinkers happier with their college social experience

Why do some colleges have persistently high levels of binge drinking? It may be because, at these schools, binge drinking is associated with high status and binge drinkers are happier with their college social experience than their non-binge drinking peers, suggests new research to be presented at the 107th Annual Meeting of the American Sociological Association.

20 Aug 2012

Secondhand smoke exposure decreases sensitivity to cough-eliciting respiratory irritants in children

New research from the Monell Center reveals that exposure to secondhand smoke decreases sensitivity to cough-eliciting respiratory irritants in otherwise healthy children and adolescents.

20 Aug 2012

Resveratrol might help improve mobility and prevent life-threatening falls among older people

In a stride toward better health in later life, scientists reported today that resveratrol, the so-called "miracle molecule" found in red wine, might help improve mobility and prevent life-threatening falls among older people.

20 Aug 2012

New evidence reveals possibility of mood-enhancing effects associated with some flavors

New evidence reveals the possibility of mood-enhancing effects associated with some flavors, stemming at least in part from natural ingredients bearing a striking chemical similarity to valproic acid, a widely used prescription mood-stabilizing drug, scientists reported here today. This effect joins those previously reported for chocolate, teas and some other known comfort foods.

20 Aug 2012

ACS National Meeting & Exposition focuses on DNA wires and their potential use in identifying diseases

In a discovery that defies the popular meaning of the word "wire," scientists have found that Mother Nature uses DNA as a wire to detect the constantly occurring genetic damage and mistakes that ― if left unrepaired ― can result in diseases like cancer and underpin the physical and mental decline of aging.

20 Aug 2012

UCP2 uncoupling protein occurs mainly in cells of the immune system

When uncoupling proteins are active, mitochondria produce heat instead of ATP. This may be useful under certain circumstances, such as when an animal is hibernating. But non-hibernating animals also have them. Particularly poorly understood is the uncoupling protein UCP2. Elena Pohl and colleagues at the University of Veterinary Medicine, Vienna, show that the protein occurs mainly in cells of the immune system.

18 Aug 2012

War does not trigger symptoms of PTSD in military personnel

A large-scale survey of the mental condition of military personnel before, during and after their posting to Afghanistan has proved thought-provoking. In total, 746 Danish soldiers took part in the survey. The soldiers completed a questionnaire five times in all - before their posting, during their time in Afghanistan and three times after their return to Denmark.

18 Aug 2012

Pulvinar regulates communication between clusters of brain cells

A mysterious region deep in the human brain could be where we sort through the onslaught of stimuli from the outside world and focus on the information most important to our behavior and survival, Princeton University researchers have found.

18 Aug 2012

Australian ruling on cigarette logo ban a 'landmark event' for global health

"The ruling this week by Australia's high court to uphold its government's right to introduce 'plain packaging' for tobacco products is a landmark event for global health," John Seffrin, CEO of the American Cancer Society, writes in this Health-e opinion piece.

18 Aug 2012

Study demonstrates how Elesclomol blocks oxidative phosphorylation in melanoma

A laboratory study led by UNC medical oncologist Stergios Moschos, MD, demonstrates how a new targeted drug, Elesclomol, blocks oxidative phosphorylation, which appears to play essential role in melanoma that has not been well-understood. Elesclomol (Synta Pharmaceuticals, Lexington, MA) was previously shown to have clinical benefit only in patients with normal serum lactate dehydrogenase (LDH), a laboratory test routinely used to assess activity of disease.

18 Aug 2012

Medical Condition News

Enrollment complete in BDSI's pivotal pharmacokinetic study of BNX for opioid dependence

FDA approves InSightec's ExAblate Neuro system clinical trial for tremor dominant Parkinson's Disease

Juventas commences treatment in JVS-100 Phase II STOP-HF trial for late stage heart failure

Protein toxic to nerve cells in AD also contributes to memory loss

Abbott's XIENCE Xpedition Everolimus Eluting Coronary Stent System receives CE Mark in Europe

Cervical cancer screening: an interview with Alastair Atkinson, CEO of DySIS Medical Ltd

GORE Hybrid Vascular Graft receives CE Mark approval

Binge drinkers happier with their college social experience

Secondhand smoke exposure decreases sensitivity to cough-eliciting respiratory irritants in children

Resveratrol might help improve mobility and prevent life-threatening falls among older people

New evidence reveals possibility of mood-enhancing effects associated with some flavors

ACS National Meeting & Exposition focuses on DNA wires and their potential use in identifying diseases

UCP2 uncoupling protein occurs mainly in cells of the immune system

War does not trigger symptoms of PTSD in military personnel

Pulvinar regulates communication between clusters of brain cells

Australian ruling on cigarette logo ban a 'landmark event' for global health

Study demonstrates how Elesclomol blocks oxidative phosphorylation in melanoma

Data from new survey shows wide variation in access to primary PCI

Computer simulations shed light on dynamic structure of major target for anti-cancer drugs

Teva launches generic ACTOplus met to improve glucose control in adults with type 2 diabetes

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Latest News